the vanderbilt p50 center: new approaches to evaluating the genetics of adverse drug reactions
Published 8 years ago • 109 plays • Length 32:23Download video MP4
Download video MP3
Similar videos
-
5:45
pharmacogenomics ~direct-to-consumer genetic testing~ (23andme)
-
52:09
applications of human genetics in drug discovery to present and future indications
-
4:19
introduction to pgrn-hub
-
1:15
new methods find undiagnosed genetic diseases in electronic health records
-
4:53
aloe vera plant medicinal uses
-
24:28
pharmacokinetics and pharmacodynamics
-
59:42
the role of genetics in parkinson's | proactive brain health
-
14:50
ddev plastiks q2 2025
-
0:33
give the major product(s) of each of the following reactions: a. bromination of p -methylbenzoic ac…
-
1:26
pharmacogenomics: what it is and how it works
-
1:44
exploratory delayed-start analysis of pasadena in early-stage parkinson's disease
-
0:47
pfizer agrees to license generic versions of paxlovid to low-income countries
-
7:50
dr. dan bloomfield on the benefits of abelacimab
-
0:49
did you know that 70% of the american population has a vitamin d deficiency?
-
20:18
bitc / data analysis - day 5 - rafael -- zonation - 2
-
1:01:20
panel: state of play in the vector arms race: perspectives on the future of gene delivery
-
3:25
pridopidine rescues bdnf transport in a huntington’s disease brain-on-a-chip model
-
0:16
what is pharmacogenomics?
-
0:33
briefly describe the genetic structure of a typical retrovirus.
-
32:00
pdb50 at bps: linda columbus
-
3:04
use of retain® pgr in california to reduce pfa in walnuts